Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB

WHITEHEAD INSTITUTE FOR

BIOMEDICAL RESEARCH, ORDER:

13 Plaintiffs, (1) GRANTING PLAINTIFFS’ 14 v. UNOPPOSED MOTION FOR LEAVE TO FILE A FIRST AMENDED SHORELINE BIOSCIENCES, INC.; and

COMPLAINT; AND

DAN S. KAUFMAN,

Defendants. [Doc. Nos. 103, 105.]

18 (2) DENYING AS MOOT DEFENDANT SHORELINE’S

MOTION FOR LEAVE TO FILE AN

AMENDED ANSWER AND

COUNTERCLAIMS

22 [Doc. No. 88.] 23 On November 25, 2022, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed a 24 motion for leave to file an amended answer and counterclaims. (Doc. No. 88.) On 25 December 27, 2022, Plaintiffs Fate Therapeutics, Inc. (“Fate”) and Whitehead Institute of 26 Biomedical Research (“Whitehead”) filed an unopposed motion for leave to file a first 27 amended complaint. (Doc. No. 103.) In their motion for…